&
P. Stefanicˇ et al. / Tetrahedron Letters 42 (2001) 5295–5297
5297
In conclusion, an important feature of our finding is
that ethyl 4-alkyl-2-hydroxy-3-oxo-3,4-dihydro-2H-1,4-
benzoxazine-2-carboxylates 3 can be obtained in one
step from 4-alkyl-3-oxo-3,4-dihydro-2H-1,4-benzox-
azine-2-carboxylates. The novel compounds 3a–f are
interesting peptidomimetic building blocks which offer
numerous possibilities of functionalization.
related compounds. The details of both structures (CIF
files) will be deposited in the Cambridge Structural
Database.
8. The chemical shift of the exchangeable proton was
approximately 5.2 ppm in CDCl3. The by-product was
generally obtained in 5–10% yield.
9. The crude yields of 3a–f ranged from 25 to 55%.
10. Jeener, J.; Meier, B. H.; Bachmann, P.; Ernst, R. R. J.
Chem. Phys. 1979, 71, 4546–4553.
Acknowledgements
11. Bodenhausen, G.; Ruben, D. J. Chem. Phys. Lett. 1980,
69, 185–189.
12. Willker, W.; Leibfritz, D.; Kerssebaum, R.; Bermel, W.
Magn. Reson. Chem. 1993, 31, 287–292.
13. Relative to MeCN (l=−135.83 ppm) as external
reference.
This work was supported financially by the Ministry of
Science and Technology of the Republic of Slovenia,
through grants P1-502-002-00 and P1-511-103-00. The
authors wish to thank Professor Roger Pain for critical
reading of the manuscript.
14. Preparation of compound 3a (typical procedure):
To a stirred solution of ethyl 4-methyl-3-oxo-3,4-dihydro-
2H-1,4-benzoxazine-2-carboxylate 2a (0.470 g, 2.0 mmol)
in 1,4-dioxane (15 mL) cooled to 10°C, sodium hydride
(0.057 g, 2.4 mmol) was added under an argon atmo-
sphere. The reaction mixture was allowed to warm to
ambient temperature and stirred for an additional 5 h.
The solvent was evaporated in vacuo and the residue
dissolved in diethyl ether (15 mL). The solution was
rinsed with 0.1 M HCl (2×10 mL), dried over anhydrous
Na2SO4 and the solvent was removed in vacuo. The crude
product was purified by column chromatography on sil-
ica gel using dichloromethane/methanol (100/1) as eluant
to give analytically pure ethyl 4-methyl-2-hydroxy-3-oxo-
References
1. Goodman, M.; Ro, S. In Burger’s Medicinal Chemistry
and Drug Discovery; Wolff, M. E., Ed. Peptidomimetics
for drug design. John Wiley & Sons Inc.: New York,
1995; pp. 803–861.
2. Giannis, A.; Ru¨bsam, F. Adv. Drug Res. 1997, 29, 1–78.
3. Techer, H.; Pesson, M.; Dursin, M. C. R. Acad. Sc. Paris
Serie C 1969, 269, 154–157.
4. Rutar, A.; Kikelj, D. Synth. Commun. 1998, 28, 2737–
2749.
5. Marfat, A.; Carta, M. P. Synthesis 1987, 515–517.
6. Thuiller, G.; Laforest, J.; Bessin, P.; Bonnet, J.; Thuiller,
J. Eur. J. Med. Chem. 1975, 10, 37–42.
3,4-dihydro-2H-1,4-benzoxazine-2-carboxylate 3a as
a
white amorphous solid; yield: 0.115 g (23%); mp 98–
101°C; IR (KBr): w 3376, 2991, 1750, 1675, 1609, 1502,
1394, 1294, 1229, 1140, 1048, 979, 860, 753, cm−1 1H
;
7. Compound 2d crystallizes from ethanol/acetonitrile and
forms colorless prismatic crystals in the monoclinic space
NMR (300 MHz, DMSO-d6): l 1.22 (t, 3H, J=7.16 Hz,
CH2CH3), 3.31 (s, 3H, N-CH3), 4.25 (q, 2H, J=7.16 Hz,
,
group P21/c with unit cell parameters a=8.4058(1) A,
CH2CH3), 7.05–7.18 (m, 3H, Ar-H
6 ), 7.23–7.26 (m, 1H,
,
,
b=16.7340(2) A, c=10.9222(3) A, i=99.2473(4)°. Com-
pound 3a crystallizes from dichloromethane/petrolether
and forms prismatic colorless crystals in the orthorhom-
bic space group Pn21c with unit cell parameters a=
Ar-H), 8.55 (s, 1H, -OH) ppm; MS (70 eV, EI): m/z (%)
6
6
251 (M+, 28), 235 (45), 189 (6), 178 (62), 150 (23), 94 (33),
77 (100), 65 (80). Anal. calcd for C12H13NO5: C, 57.37;
H, 5.22; N, 5.48%. Found: C, 57.00; H, 5.14; N, 5.40%.
15. The authors wish to express their gratitude to the referee
for his helpful suggestion concerning the reaction mecha-
nism.
,
,
,
10.2460(2) A, b=10.3464(2) A, c=10.9830(2) A.
Diffraction data were collected at 150(1) K with Mo Ka
radiation and CCD detector. The bond lengths and
angles are normal and in agreement with the values for
.